Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan C Buckner

Showing results (61-70 of 138) with videos related to

Pageof 14
Sort By:
Journal of Neuro-Oncology|April 14, 2007
Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic gradeJan C Buckner, Judith R O'Fallon, Robert P Dinapoli, et al.
American Journal of Clinical Oncology|April 9, 2008
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of lifePaul D Brown, Paul A Decker, Teresa A Rummans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Detrimental effects of tumor progression on cognitive function of patients with high-grade gliomaPaul D Brown, Ashley W Jensen, Sara J Felten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancerManuel Hidalgo, Jan C Buckner, Charles Erlichman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigationShauna L Hillman, Sumithra J Mandrekar, Brian Bot, et al.
Journal of Geriatric Oncology|May 21, 2016
Pragmatic study designs for older adults with cancer: Report from the U13 conferenceRyan D Nipp, Nengliang Aaron Yao, Lisa M Lowenstein, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2010
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiformeJann N Sarkaria, Evanthia Galanis, Wenting Wu, et al.
Cancer|April 25, 2003
Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment GroupJan C Buckner, Joel M Reid, Keith Wright, et al.
Seminars in Oncology|October 22, 2008
North Central Cancer Treatment Group--achievements and perspectivesAxel Grothey, Alex A Adjei, Steve R Alberts, et al.
Journal of Neuro-Oncology|August 14, 2014
Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumorRachael A Lester, Lindsay C Brown, Laurence J Eckel, et al.
Pageof 14

Showing results (61-70 of 138) with videos related to

Sort By:
Pageof 14
Journal of Neuro-Oncology|April 14, 2007
Prognosis in patients with anaplastic oligoastrocytoma is associated with histologic gradeJan C Buckner, Judith R O'Fallon, Robert P Dinapoli, et al.
American Journal of Clinical Oncology|April 9, 2008
A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: comparison of patient and caregiver ratings of quality of lifePaul D Brown, Paul A Decker, Teresa A Rummans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Detrimental effects of tumor progression on cognitive function of patients with high-grade gliomaPaul D Brown, Ashley W Jensen, Sara J Felten, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2006
A phase I and pharmacokinetic study of temsirolimus (CCI-779) administered intravenously daily for 5 days every 2 weeks to patients with advanced cancerManuel Hidalgo, Jan C Buckner, Charles Erlichman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigationShauna L Hillman, Sumithra J Mandrekar, Brian Bot, et al.
Journal of Geriatric Oncology|May 21, 2016
Pragmatic study designs for older adults with cancer: Report from the U13 conferenceRyan D Nipp, Nengliang Aaron Yao, Lisa M Lowenstein, et al.
International Journal of Radiation Oncology, Biology, Physics|September 25, 2010
North Central Cancer Treatment Group Phase I trial N057K of everolimus (RAD001) and temozolomide in combination with radiation therapy in patients with newly diagnosed glioblastoma multiformeJann N Sarkaria, Evanthia Galanis, Wenting Wu, et al.
Cancer|April 25, 2003
Irinotecan in the treatment of glioma patients: current and future studies of the North Central Cancer Treatment GroupJan C Buckner, Joel M Reid, Keith Wright, et al.
Seminars in Oncology|October 22, 2008
North Central Cancer Treatment Group--achievements and perspectivesAxel Grothey, Alex A Adjei, Steve R Alberts, et al.
Journal of Neuro-Oncology|August 14, 2014
Clinical outcomes of children and adults with central nervous system primitive neuroectodermal tumorRachael A Lester, Lindsay C Brown, Laurence J Eckel, et al.
Pageof 14